The P-Shot (PRP): Does Platelet-Rich Plasma Work for Enhancement?

What Is PRP?

Platelet-rich plasma (PRP) is a blood product made from the patient's own blood. A sample of venous blood — typically 10-60 mL depending on the system and protocol — is drawn into specialized tubes and placed in a centrifuge. The centrifugation process separates the blood into its component layers: red blood cells (heavy, settle to the bottom), a buffy coat layer containing platelets and white blood cells, and platelet-poor plasma on top. The platelet-rich fraction is extracted, producing a concentrate that contains platelets and their associated growth factors at several times the concentration found in whole blood.[1]

PRP has legitimate applications in several areas of medicine. In orthopedics, it is used for tendon injuries, osteoarthritis, and post-surgical healing with varying levels of evidence. In dermatology, it is used for hair restoration (androgenetic alopecia) with moderate evidence. In wound care, it has an established role in promoting healing of chronic wounds. The evidence base varies significantly by application — from well-supported to speculative. Its application to penile enhancement falls into the speculative category.

PRP Biology: What Growth Factors Actually Do

Understanding what PRP can and cannot do requires understanding what growth factors actually do at the cellular level. Platelets contain alpha granules that release several key growth factors when activated, including platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-β), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and insulin-like growth factor (IGF-1).

These growth factors play roles in tissue repair: they stimulate cell proliferation, promote new blood vessel formation (angiogenesis), recruit stem cells to injury sites, and modulate inflammation. In the context of injured tissue — a torn tendon, a surgical wound, a damaged hair follicle — these activities can meaningfully accelerate or improve healing.

However, tissue repair and tissue growth are fundamentally different processes. Growth factors help damaged tissue rebuild to its original state. They do not cause healthy, undamaged tissue to expand beyond its normal dimensions. A healthy tendon treated with PRP does not become larger than it was before. A PRP-treated scalp does not grow thicker skin. The growth factors signal repair and regeneration — not expansion of normal, intact anatomy.

This distinction is critical for evaluating size claims. The penile tissue of a healthy adult male seeking enhancement is not damaged or degenerated — it is functioning normally. The claim that injecting growth factors into healthy penile tissue will cause it to grow larger would require a biological mechanism that has not been demonstrated in any tissue type, not just penile tissue. For a detailed overview of the structures involved, see Penile Anatomy.

The Preparation Variability Problem

A significant issue with PRP research — and with clinical PRP use in general — is that "PRP" is not a standardized product. The concentration of platelets and growth factors in the final preparation varies enormously depending on several factors:

• Centrifuge system: Different commercial PRP systems (and there are dozens on the market) use different centrifugation speeds, durations, and tube designs, producing PRP with different platelet concentrations and compositions.
• Blood volume drawn: More initial blood generally allows for more concentrated PRP, but protocols vary from 10 mL to 60 mL or more.
• Single vs double spin: Some protocols use a single centrifugation, while others use a double-spin technique that produces higher platelet concentration.
• Leukocyte content: Some systems produce leukocyte-rich PRP (LR-PRP), which contains white blood cells and may have different inflammatory properties than leukocyte-poor PRP (LP-PRP). The optimal choice depends on the application, and there is no consensus for penile use.
• Activation method: PRP can be injected unactivated (relying on the body's collagen to trigger platelet activation) or pre-activated with calcium chloride or thrombin. These approaches release growth factors on different timelines.
• Patient variability: Individual patients' blood contains different baseline platelet counts, and platelet function varies with age, medications, and health status.

The practical consequence is that "PRP" from one provider's office may be a fundamentally different product than "PRP" from another provider's office — even when both are marketed as the same procedure. This makes it extremely difficult to compare results between studies, replicate outcomes, or tell patients what they should expect. A treatment that cannot be standardized is a treatment that cannot be reliably evaluated.

The P-Shot Procedure

The P-Shot (Priapus Shot) involves a blood draw, centrifugation to prepare PRP, application of a topical numbing cream to the penis, and injection of the PRP into multiple sites on the shaft and glans. The entire process takes approximately 30-60 minutes, including the centrifugation time. Some providers apply a vacuum pump device immediately before or after injection, claiming this enhances PRP distribution and cellular uptake.

Proponents claim that the growth factors in PRP stimulate tissue regeneration, improve blood flow, increase sensitivity, and produce permanent increases in both girth and length. These are significant claims. Each requires significant evidence to support — and the evidence currently available does not meet that threshold for any of them.

The procedure is typically recommended as a series of treatments (2-3 sessions spaced 4-8 weeks apart) rather than a single session, at a cost that varies by provider and market (see current pricing for comparison). Some providers recommend ongoing maintenance treatments every 12-18 months.

The Trademarked Procedure Business Model

The P-Shot is a trademarked name for a specific PRP injection protocol. Providers who wish to market the procedure under this trademarked name pay a licensing fee and complete a training program. This business model creates a network of providers who all use the same branding and marketing language, which can create an impression of standardization and broad clinical adoption that may not reflect the actual state of the evidence.

The trademarked model is not unique to the P-Shot — it exists across aesthetic medicine. It is important for patients to understand that a trademarked procedure name is a marketing and business structure, not a mark of scientific validation. A treatment being widely offered by many providers tells you about its commercial viability, not its clinical efficacy. Many profitable aesthetic procedures have weak evidence bases. The critical question is not "how many clinics offer this?" but "what does the peer-reviewed literature show?"

The Size Enhancement Claim

The claim that PRP injection can produce permanent increases in penile size is not supported by published clinical evidence. No controlled trial has demonstrated measurable girth or length gains from PRP alone.

This makes biological sense when you consider what PRP does and does not do. PRP provides growth factors that may stimulate cellular activity and tissue repair. However, it does not add physical volume to tissue. A few milliliters of PRP injected into the shaft is a liquid blood product that will be absorbed by the body within days — it does not persist in the tissue the way a cross-linked hyaluronic acid gel does. The growth factors it releases operate for a period of days to weeks before being cleared.[2]

For permanent size increase, you need either additional physical material that persists (filler, fat graft, implant) or the growth of new structural tissue. There is no evidence that PRP stimulates the growth of new penile tissue in quantities sufficient to produce a measurable dimensional change. The collagen and smooth muscle tissue of the penile shaft do not respond to growth factor signaling with volumetric expansion in the way that, for example, a healing wound generates new tissue to close a defect.

Some patients report that the penis appears temporarily larger after the P-Shot procedure — this is likely attributable to the volume of the injected liquid itself (which is absorbed within days), local swelling from the injection, and the vasodilatory effects of the procedure (improved blood flow producing a temporarily fuller flaccid state). None of these represent structural size increase.

The Erectile Function Claim

The evidence for PRP improving erectile function is somewhat more nuanced than the size claim, though still preliminary. Several small studies have reported improvements in erectile function scores after penile PRP injection:

• A 2020 pilot study of 40 men with mild to moderate ED reported improvements in IIEF (International Index of Erectile Function) scores at 3 and 6 months after PRP injection, compared to baseline.[3]
• A 2021 systematic review by Shaher et al. examined available studies and concluded that while initial data is "promising," the evidence suffers from small sample sizes, short follow-up periods, lack of adequate controls, and heterogeneous PRP preparation methods. The authors noted that well-designed randomized controlled trials are needed before clinical recommendations can be made.[4]
• Several case series from individual providers report high patient satisfaction scores, though these are subject to significant bias (no blinding, no control group, patients who paid for the procedure are motivated to report positive outcomes).

The honest assessment: there may be biological plausibility to the erectile function application — VEGF-mediated angiogenesis could theoretically improve penile blood supply, and growth factors might improve cavernosal smooth muscle function. But the data is not yet strong enough to recommend PRP as a standard treatment for ED. Established treatments — PDE5 inhibitors, vacuum erection devices, intracavernosal injections, and for refractory cases, penile prostheses — have far stronger evidence bases and more predictable outcomes. For more on the physiology of erections, see How Erections Work.

The Sensitivity and Sensation Claim

Some P-Shot providers market the procedure as a way to improve penile sensitivity and sexual sensation. This claim is even more difficult to evaluate than the size or ED claims because sensation is entirely subjective and highly susceptible to placebo effects.

No published study has used objective neurophysiological measurements (such as vibratory threshold testing or nerve conduction studies) to demonstrate improved penile nerve function after PRP injection. The studies that report improved sensation rely on patient self-report, which cannot distinguish between a genuine neurological change and a placebo-mediated perception change. In a procedure where the patient has invested significantly and expects improvement, the psychological motivation to perceive improvement is substantial.

This does not mean the reported improvements are not real to the patients experiencing them — subjective experience matters. But it does mean the claim cannot be attributed to PRP's biological mechanism versus the powerful combination of expectation, investment, and attention to one's sexual experience that accompanies any sexual health procedure.

Marketing vs Evidence

The P-Shot illustrates a broader pattern in elective medicine: the marketing substantially outpaces the evidence. A search for "P-Shot" returns pages of clinic websites making confident claims about size enhancement, improved sensation, and sexual performance — claims that are not adequately supported by the published literature.

Marketing materials for the P-Shot frequently use language designed to create an impression of scientific credibility: "growth factor technology," "regenerative medicine," "stem cell activation," "cellular rejuvenation." These terms are not inaccurate descriptions of PRP biology in general, but they are used in a context (penile size enhancement) where the specific application has not been validated. The language borrows credibility from legitimate PRP applications and transfers it to an unproven one.

This does not necessarily mean PRP is ineffective for all claimed applications. It means that the current evidence is insufficient to support the claims being made in marketing, and patients should be cautious about investing significant money in a treatment whose primary support comes from marketing materials rather than peer-reviewed data.

When evaluating any treatment, a useful question is: "If this worked as well as claimed, wouldn't it be standard of care by now?" PRP has been available for penile injection for over a decade. If it reliably produced the size gains and functional improvements its marketing claims, the peer-reviewed evidence would reflect that — and major urology societies would have incorporated it into treatment guidelines. Neither has happened.

Cost and Value Analysis

The P-Shot involves significant per-session costs, with many providers recommending 2-3 sessions for "optimal results" and ongoing maintenance treatments. A full initial course can add up substantially.

For this investment, the patient receives a treatment with no demonstrated ability to increase size, preliminary evidence for modest erectile function improvement, and subjective reports of improved sensation that cannot be distinguished from placebo effect. The patient's own blood product is processed and re-injected — the material cost to the provider is minimal, and the procedure takes 30-60 minutes of clinical time.

By comparison, the same investment could fund a filler enhancement procedure that produces immediately visible, measurable girth results with an established safety profile and the ability to be reversed if unsatisfactory — or multiple sessions of evidence-based ED treatment. Patients should weigh what they are paying for against the strength of the evidence supporting the expected outcome.

PRP vs HA Filler

These are typical results. Your own result will depend on your starting size and the volume of filler used, and your provider will explain what you can expect at your consultation.

For patients seeking measurable girth enhancement, HA filler has a substantially stronger evidence base and produces immediately visible, quantifiable results. For more on filler-based enhancement, see Penis Filler: How It Works. For the complete comparison of all methods, see the complete guide to penis enlargement options.

Frequently Asked Questions

Does the P-Shot increase penis size?

No controlled clinical trial has demonstrated measurable, permanent size increases from PRP injection. PRP does not add physical volume the way filler does — it is a liquid blood product that is absorbed by the body within days. Any temporary fullness observed after the procedure is attributable to the injected liquid volume and local swelling, not structural tissue growth.

Is PRP the same as filler?

No. PRP is the patient's own concentrated blood product containing growth factors. It does not persist in tissue or add volume. HA filler is a cross-linked hyaluronic acid gel that physically occupies space and produces immediately measurable girth increase that lasts approximately 24 months. They work through completely different mechanisms and produce different outcomes.

Is the P-Shot safe?

Because PRP is derived from the patient's own blood, allergic reactions are extremely rare and the risk of immune rejection is essentially zero. The injection itself carries the standard risks of any penile injection — bruising, swelling, discomfort, and a small risk of infection. The primary concern with the P-Shot is not safety but efficacy: is the cost justified by the evidence supporting the claimed outcomes?

Does PRP work for erectile dysfunction?

The evidence is preliminary and insufficient for clinical recommendation. Several small studies suggest possible improvements in erectile function scores, but these studies lack adequate controls, use small sample sizes, have short follow-up periods, and use variable PRP preparations. Established ED treatments — including PDE5 inhibitors, vacuum devices, and intracavernosal injections — have far stronger evidence bases. Men with erectile concerns should consult a urologist for evidence-based evaluation and treatment.

Why do some clinics show "before and after" results for the P-Shot?

Before and after photographs in the context of PRP injection should be evaluated very carefully. Differences between photos can be attributable to erection quality (a fuller erection at the "after" visit), lighting and angle differences, temporary swelling from the injection, or the effects of concurrent treatments (some providers combine PRP with filler but attribute the result to PRP). Without controlled measurements and standardized photography conditions, before-and-after photos are anecdotal marketing, not clinical evidence.

What if my provider recommends combining PRP with filler?

Some providers offer PRP as an add-on to filler enhancement, hypothesizing that growth factors improve tissue integration. This is theoretically plausible but clinically unproven in the penile context. If you choose this combination, understand that the measurable girth result comes from the filler component. The PRP add-on's incremental benefit has not been demonstrated, and you should evaluate whether its additional cost is justified by the current evidence.

How many sessions does the P-Shot require?

Most providers recommend 2-3 initial sessions spaced 4-8 weeks apart, with some recommending annual or biannual maintenance treatments. A full initial course represents a significant financial commitment. Given the lack of controlled evidence for the claimed outcomes, patients should consider this total investment — not just the per-session cost — when evaluating the treatment.

For clinicians: penis filler training and certification.